Help-Line 01233 334 879

 

Proventus

Working together to make a difference

Find Us Here

You tube
Follow Provpeter on Twitter
You Tube
twitter

Recent Additions 2009

Dec                                                                                                                                                                                                                                              

SF1019 possible court actions

Nov                                                                                                                                                                                                                                               

Chronic Cerebrospinal Venous Insufficiency - CCSVI

Sept                                                                                                                                                                                                                                             

Multiple Sclerosis and Whole Body Vibration Technology (WBVT)

Seasonal Flu shot may increase H1N1 risk - CBC News

BT Telephone Scam Warning (takes you to BT web site)

Are Bacteria the Root Cause of MS and Other "Auto-Immune" Disorders?

Lyme Disease Epidemic Causing Healthcare Crisis - USA

Blood Test May Predict Course Of MS - MS News

Dirucotide Does Not Meet Primary Endpoint In Phase III MAESTRO-01 Trial In Secondary Progressive Multiple Sclerosis - Medical News Today

Researchers at Aurora St. Luke's Medical Center in Milwaukee report that plasma exchange therapy or PLEX dramatically improves the health of multiple sclerosis patients who fail to respond to conventional therapies. Newscom (off site)  Aurora (off site)

Acorda Therapeutics Reports Date of FDA Advisory Committee Review of Fampridine-SR for Improvement of Walking Ability in People with MS (off site)

A Natural Break-through in Infection Control

MS is Big Bucks

The Multiple Sclerosis (MS) Market Has Total Global Revenues of Over $6bn in 2008. It Will Exceed $9bn During the Second Half of Next Decade.

Source - Visiongain (off site)

Leading causes of paralysis in the US

August                                                                                                                                                                                                                                         

Assisted Suicide (Don't book a ticket to Dignitas just yet) Times Online

LDN Awareness week 19th - 25th October. ldnresearchtrust

July 2009

A patent for 'The Treatment of HIV' has been added to the AIMSPRO IP portfolio, having an effective date of 31st March 2009. Aimspro

June                                                                                                                                                                                                                                            

KIB 500

May                                                                                                                                                                                                                                              

The Australian Government, through the Department of Health and Ageing, has designated AIMSPRO as an orphan drug for use in the treatment of amyotrophic lateral sclerosis with effect from 15 May 2009. Aimspro Orphan Status

April                                                                                                                                                                                                                                              

Oral MS drug, Cladribine, appears effective, but cancer cases raise concerns

Anti-Inflammatory drugs without the side effects - a safer approach - Medical News Today

Low Dose Naltrexone (LDN) appears to relieve Fibromyalgia Pain

March                                                                                                                                                                                                                                           

Dangerously high levels of undeclared pharmaceuticals have been discovered in a supposed ‘Herbal Viagra’ being sold in many Traditional Chinese Medicine (TCM) stores in the United Kingdom.MHRA Alert

MS Neurologists Skittish On Side Effects - MS News

Scleroderma & Aimspro trial - Sclero.org

Feb                                                                                                                                                                                                                                               

Scleroderma & Aimspro trial Sclero.org

Jan                                                                                                                                                                                                                                               

Stem Cell Research Published  The Guardian  The Lancet

New Death Reported - Tysabri

Study links Gene Varient and Vitamin D to MS Risk Reuters  PloS Genetics

Online Poll result - UK (2008).

“Is the data from clinical trials reliable? French judges probe firms over vaccinations.” - London.

“Caregivers and quality of life in the US” - USA

“What was the Guardian article all about?” - London.

“Attacking Proventus” - USA.

“In response to the Guardian Article” - Hertfordshire.

“The Pharmacist who mishandled Aimspro” - Kent.

“Misconduct of the overseeing Pharmacist” - Surrey.

“There really is something going on” - Lancashire.

“AIMSPRO at St.George's Hospital” - Glasgow.

“Alan Osmond travelled to England to be treated with Aimspro” - London.

“Alan Osmond - a shareholder in SF1019?” - London.

“Consternation within the MS community is being caused by confusion” - London

Lyme Disease Ticks Don’t Come Out In The Wash

AIMSPRO® bowel & bladder trial in multiple sclerosis (MS) Trial

A double-blind placebo-controlled pilot study of safety and tolerability of AIMSPRO® in established diffuse cutaneous systemic sclerosis Trial